172@29@16@17!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=0&is_revamped_header=0&is_responsive=1&sec=PNC_FINANCIAL&priceinter=1&frommc=1!~!|commonstore|commonfiles|moneycontrol_header.php
Moneycontrol
SENSEX NIFTY
you are here:

AstraZeneca Pharma Ltd.

BSE: 506820 | NSE: ASTRAZEN |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE203A01020 | SECTOR: Pharmaceuticals

BSE Live

Aug 13, 16:00
3355.00 -0.90 (-0.03%)
Volume
AVERAGE VOLUME
5-Day
3,442
10-Day
3,070
30-Day
4,015
2,317
  • Prev. Close

    3355.90

  • Open Price

    3323.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Aug 13, 15:59
3350.75 -4.10 (-0.12%)
Volume
AVERAGE VOLUME
5-Day
64,579
10-Day
60,039
30-Day
59,391
21,664
  • Prev. Close

    3354.85

  • Open Price

    3355.00

  • Bid Price (Qty.)

    3350.75 (18)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2019 2018 2017 2016 2015
Key Financial Ratios of AstraZeneca Pharma (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
Per Share Ratios  
Basic EPS (Rs.) 28.66 21.80 10.40 8.00 2.10  
Diluted EPS (Rs.) 28.66 21.80 10.40 8.00 2.10  
Cash EPS (Rs.) 36.32 27.75 16.26 14.35 9.07  
Book Value [ExclRevalReserve]/Share (Rs.) 145.77 120.32 98.77 89.15 62.41  
Book Value [InclRevalReserve]/Share (Rs.) 145.77 120.32 98.77 89.15 62.41  
Dividend / Share(Rs.) 1.00 0.00 0.00 0.00 0.00  
Revenue from Operations/Share (Rs.) 332.72 291.32 228.40 217.48 225.49  
PBDIT/Share (Rs.) 53.47 35.04 23.42 20.53 9.28  
PBIT/Share (Rs.) 46.04 29.07 17.52 14.20 2.31  
PBT/Share (Rs.) 45.58 29.07 17.52 14.20 2.31  
Net Profit/Share (Rs.) 28.88 21.78 10.36 8.02 2.10  
Profitability Ratios  
PBDIT Margin (%) 16.07 12.02 10.25 9.44 4.11  
PBIT Margin (%) 13.83 9.97 7.67 6.52 1.02  
PBT Margin (%) 13.70 9.97 7.67 6.52 1.02  
Net Profit Margin (%) 8.68 7.47 4.53 3.68 0.93  
Return on Networth / Equity (%) 19.81 18.10 10.49 8.99 3.37  
Return on Capital Employed (%) 30.35 23.99 17.27 15.76 3.34  
Return on Assets (%) 10.22 9.69 5.62 4.82 1.29  
Total Debt/Equity (X) 0.00 0.00 0.00 0.00 0.00  
Asset Turnover Ratio (%) 117.75 129.63 123.98 130.85 138.94  
Liquidity Ratios  
Current Ratio (X) 1.81 1.56 1.55 1.32 1.08  
Quick Ratio (X) 1.30 1.11 1.00 1.02 0.77  
Inventory Turnover Ratio (X) 5.04 6.17 5.05 9.42 7.35  
Dividend Payout Ratio (NP) (%) 0.00 0.00 0.00 0.00 0.00  
Dividend Payout Ratio (CP) (%) 0.00 0.00 0.00 0.00 0.00  
Earnings Retention Ratio (%) 0.00 0.00 0.00 0.00 0.00  
Cash Earnings Retention Ratio (%) 0.00 0.00 0.00 0.00 0.00  
Valuation Ratios  
Enterprise Value (Cr.) 5,726.36 4,822.45 2,190.33 2,236.17 2,814.79  
EV/Net Operating Revenue (X) 6.88 6.62 3.84 4.11 4.99  
EV/EBITDA (X) 42.84 55.06 37.42 43.56 121.38  
MarketCap/Net Operating Revenue (X) 7.19 6.86 4.06 4.33 5.13  
Retention Ratios (%) 0.00 0.00 0.00 0.00 0.00  
Price/BV (X) 16.41 16.61 9.38 10.55 18.53  
Price/Net Operating Revenue 7.19 6.86 4.06 4.33 5.13  
Earnings Yield 0.01 0.01 0.01 0.01 0.00  
Source : Dion Global Solutions Limited